Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
1985 • 1,928 citations
Interleukin-6 family of cytokines and gp130
1995 • 1,314 citations
Molecular Regulation of B Lymphocyte Response
1988 • 579 citations
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
1989 • 501 citations
Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas
1989 • 420 citations
Human soluble IL-6 receptor: its detection and enhanced release by HIV infection.
1992 • 342 citations
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
1993 • 233 citations
Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures.
1990 • 226 citations
Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer
1991 • 214 citations
High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.
1989 • 185 citations
Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma
1999 • 172 citations
Serum levels of interleukin 6 in patients with lung cancer
1995 • 169 citations
Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma.
1996 • 156 citations
Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.
1990 • 154 citations
Marked Elevation of Serum Interleukin-6 in Patients With Cholangiocarcinoma
1998 • 145 citations
Serum Interleukin-10 But Not Interleukin-6 Is Related to Clinical Outcome in Patients With Resectable Hepatocellular Carcinoma
2000 • 143 citations
Serum interleukin-6 levels reflect disease status of gastric cancer.
1996 • 137 citations
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver
1998 • 133 citations
Interleukin-6, Nitric Oxide, and the Clinical and Hemodynamic Alterations of Patients With Liver Cirrhosis
1999 • 116 citations
Interleukin-6 in Renal Cell Carcinoma
1992 • 114 citations
Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.
1991 • 91 citations
Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus
1997 • 91 citations
Blocking signaling through the gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity
1999 • 80 citations
Circulating IL‐6 and sIL‐6R in Patients with Hepatocellular Carcinoma
2002 • 63 citations
Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
1996 • 62 citations
Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.
1999 • 61 citations
Interleukin-6 Activity in Urine and Serum in Patients with Bladder Carcinoma
1992 • 52 citations
Circulating IL‐6‐type cytokines and sIL‐6R in patients with multiple myeloma
1999 • 50 citations
Elevated serum interleukin-6 levels in patients with acute hepatitis
1992 • 46 citations
Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein.
1990 • 45 citations
The Influence of Interleukin-6 on the Growth of Human Esophageal Cancer Cell Lines
1996 • 42 citations
[Role of interleukin 6 in hepatocellular carcinoma].
1996 • 33 citations
Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis
1993 • 30 citations
Interleukin-6 production by human melanoma cell lines.
1992 • 22 citations
Downregulation of wild-type β-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine?
2001 • 16 citations
Inhibition of growth of human hepatoma cells by dual-function antisense IL-6 oligonucleotides
2002 • 9 citations